Sunday, May 28, 2023
Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.
Disclosures for additional planners can be found here.
Professor of Neurology and Pediatrics
Division of Pediatric Neurology
Columbia University Medical Center
New York, New York
Professor of Neurology
David Geffen School of Medicine
University of California
Los Angeles, California
Child Neurologist and Neuromuscular Section Head
The Children's Hospital of Philadelphia
Philadelphia, Pennsylvania
Neurologist With Special Qualification in Child Neurology
Pediatric Neuromuscular Neurologist
Medical Director, Neurology and Neuromuscular Care Center
President, Neurology Rare Disease Center
Dallas, Texas
Professor of Neurology and Pediatrics
University of Rochester
Rochester, New York
Professor of Neurology
Harvard Medical School
Associate Neurologist-in-Chief
Chief, Division of Clinical Neurology
Director, Neuromuscular Center and SMA Program
Boston Children's Hospital
Boston, Massachusetts
Professor of Neurology
Division of Neuromuscular
The Ohio State University
Wexner Medical Center
Columbus, Ohio
This activity has been peer reviewed and the reviewer has no relevant financial relationships.
Physicians - maximum of 2.25 AMA PRA Category 1 Credit(s)™
Nurses - 2.25 ANCC Contact Hour(s) (1 contact hours are in the area of pharmacology)
This initiative is intended for neurologists, nurse practitioners (NPs), and nurses involved in the care of patients with rare neuromuscular diseases.
The goal of this activity is for learners to be better able to manage patients with pediatric neuromuscular disorders.
Upon completion of this activity, participants will:
Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.
Disclosures for additional planners can be found here.
Professor of Neurology and Pediatrics
Division of Pediatric Neurology
Columbia University Medical Center
New York, New York
Professor of Neurology
David Geffen School of Medicine
University of California
Los Angeles, California
Child Neurologist and Neuromuscular Section Head
The Children's Hospital of Philadelphia
Philadelphia, Pennsylvania
Neurologist With Special Qualification in Child Neurology
Pediatric Neuromuscular Neurologist
Medical Director, Neurology and Neuromuscular Care Center
President, Neurology Rare Disease Center
Dallas, Texas
Professor of Neurology and Pediatrics
University of Rochester
Rochester, New York
Professor of Neurology
Harvard Medical School
Associate Neurologist-in-Chief
Chief, Division of Clinical Neurology
Director, Neuromuscular Center and SMA Program
Boston Children's Hospital
Boston, Massachusetts
Professor of Neurology
Division of Neuromuscular
The Ohio State University
Wexner Medical Center
Columbus, Ohio
This activity has been peer reviewed and the reviewer has no relevant financial relationships.
Medscape, LLC designates this enduring material for a maximum of 2.25 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Awarded 2.25 contact hour(s) of nursing continuing professional development for RNs and APNs; 1.0 contact hours are in the area of pharmacology.
For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]
There are no fees for participating in or receiving credit for this online educational activity. For information on applicability
and acceptance of
continuing education credit for this activity, please consult your professional licensing board.
This activity is designed to be completed within the time designated on the title page; physicians should claim only those
credits that reflect the
time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the
valid credit period that
is noted on the title page. To receive
AMA PRA Category 1 Credit™, you must receive a minimum score of 75% on the post-test.
Follow these steps to earn CME/CE credit*:
You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it.
Credits will be tallied in
your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as
the certificates from the
CME/CE Tracker.
*The credit that you receive is based on your user profile.
CME / CE Released: 10/11/2022
Valid for credit through: 10/11/2023
processing....
All sections of this activity are required for credit.
Before you begin this activity, please assess your clinical knowledge by completing this brief survey. Answering these questions again after the activity will allow you to see what you learned and to compare your answers with those of your peers.
